Literature DB >> 10534467

Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study.

E Di Girolamo1, C Di Iorio, L Leonzio, P Sabatini, A Barsotti.   

Abstract

BACKGROUND: Recurrent syncope represents a debilitating disorder and quality of life deteriorates as a function of recurrence of symptoms. Although the administration of beta-blockers, vasoconstrictors, fludrocortisone, and serotonin reuptake inhibitors may be helpful in preventing episodes, many patients are intolerant of or respond poorly to these agents. Orthostatic training has been reported to be effective in preventing refractory syncope. Thus, to determine whether a tilt training program could prevent symptoms in adolescents, the following controlled study was undertaken. METHODS AND
RESULTS: Forty-seven consecutive adolescents (18 male and 29 female, mean age 16.0+/-2.2 years) with recurrent syncope and positive head-up tilt test refractory to previous traditional therapies were distributed between 2 groups, depending on their consent (24 patients) or refusal (controls, 23 patients) to enter the program. Orthostatic training was started, in the presence of a family member, with a series of 5 in-hospital sessions. The 24 patients and their relatives were then instructed to perform the tilt training at home by standing against a wall twice a day for a planned duration of up to 40 minutes, depending on the in-hospital orthostatic tolerance. Head-up tilt response was reevaluated after 1 month, and the clinical effect was noted over a mean follow-up of 18. 2+/-5.3 months (range 15 to 23); 26.1% of patients in the control group and 95.8% of patients in the training group became tilt-negative (P<0.0001). Spontaneous syncope was observed in 56.5% versus 0% in the control and training group, respectively (P<0.0001).
CONCLUSIONS: Orthostatic training was found to significantly improve symptoms of adolescents with neurocardiogenic syncope unresponsive to or intolerant of traditional medications. Twice-a-day training sessions of 40 minutes were well accepted by patients.

Entities:  

Mesh:

Year:  1999        PMID: 10534467     DOI: 10.1161/01.cir.100.17.1798

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  Neurally mediated syncope.

Authors:  M Zaqqa; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

2.  Vasodepressor Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

3.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

4.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

5.  The ACCF/AHA scientific statement on syncope: a document in need of thoughtful revision.

Authors:  D G Benditt
Journal:  Clin Auton Res       Date:  2006-09-29       Impact factor: 4.435

6.  Human and monkey prolactin and growth hormone: separation of polymorphic forms by isoelectric focusing.

Authors:  B C Hummel; G M Brown; P Hwang; H G Friesen
Journal:  Endocrinology       Date:  1975-10       Impact factor: 4.736

7.  Management of syncope in pediatric patients.

Authors:  Anjan S Batra; Seshadri Balaji
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

Review 8.  Syncope: investigation and treatment.

Authors:  Satish R Raj; Robert S Sheldon
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 9.  Nonpharmacological treatment of reflex syncope.

Authors:  Wouter Wieling; Nancy Colman; C T Paul Krediet; Roy Freeman
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

10.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.